Home › Funds › Rock Springs Capital Management LP › RYTM
Rock Springs Capital Management LP position in RYTM
RHYTHM PHARMACEUTICALS INC · Health Care
Rock Springs Capital Management LP reported holding 692,598 shares of RYTM (RHYTHM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$65.9M, representing 3.57% of its reported portfolio and ranking #6 among its reported holdings. Rock Springs Capital Management LP has disclosed RYTM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rock Springs Capital Management LP's RYTM position evolved
Rock Springs Capital Management LP first disclosed a stake in RYTM in Q3 2023 at 1,597,123 shares (US$36.6M). The position peaked in Q2 2026 at 692,598 shares, worth US$76.9M. Across 13 filings, Rock Springs Capital Management LP increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 692,598 shares valued at US$65.9M. Notable position changes include a 28% trim in Q1 2025 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.60M | $36.61M | New |
| Q4 2023 | 1.52M | $70.01M | Reduce |
| Q1 2024 | 1.52M | $65.99M | Hold |
| Q2 2024 | 1.28M | $52.58M | Reduce |
| Q3 2024 | 1.23M | $64.34M | Reduce |
| Q4 2024 | 1.16M | $65.09M | Reduce |
| Q1 2025 | 834.19K | $44.19M | Reduce |
| Q2 2025 | 861.15K | $54.42M | Add |
| Q3 2025 | 717.10K | $72.42M | Reduce |
| Q4 2025 | 695.01K | $74.39M | Reduce |
| Q1 2026 | 689.75K | $59.99M | Reduce |
| Q2 2026 | 692.60K | $76.90M | Hold |
| Q3 2026 | 692.60K | $65.95M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RYTM and 13F data
RYTM (RHYTHM PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in RYTM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$740.2M), BAKER BROS. ADVISORS LP (US$622.3M), PERCEPTIVE ADVISORS LLC (US$287.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RYTM
- RA CAPITAL MANAGEMENT, L.P. 6.67M sh · $740.22M · Q2 2026
- BAKER BROS. ADVISORS LP 5.60M sh · $622.27M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.59M sh · $287.16M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 2.48M sh · $236.20M · Q3 2026
- Checkpoint Capital L.P. 1.22M sh · $115.84M · Q3 2026
- Siren, L.L.C. 1.09M sh · $103.43M · Q3 2026
- Sofinnova Investments, Inc. 534.54K sh · $50.90M · Q3 2026
More on Rock Springs Capital Management LP
FAQ
How long has Rock Springs Capital Management LP held RYTM?
Rock Springs Capital Management LP has disclosed RYTM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Rock Springs Capital Management LP's current position in RYTM?
As of Q3 2026, Rock Springs Capital Management LP holds 692.60K shares of RYTM (RHYTHM PHARMACEUTICALS INC), valued at $65.95M, representing 3.57% of its reported portfolio and ranking #6.
Has Rock Springs Capital Management LP been buying or selling RYTM?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP held unchanged its position in RYTM. The position peaked in Q2 2026 at 692.60K shares.
Which other funds hold RYTM?
Other major institutional holders of RYTM include RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, PERCEPTIVE ADVISORS LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.